Shenzhen Hepalink Pharmaceutical

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 24, 2016	Kymab	$100.9M Series C	Simone Song	Bill & Melinda Gates Foundation, CF Woodford Equity Income Fund, Malin Corporation, Woodford Patient Capital Trust

Total Raised

N/A

Valuation

N/A